Healthcare information provider Wolters Kluwer Health has announced that its Medi-Span Controlled Substances Drug File has been selected by Health Market Science (HMS), a supplier of provider data and end-to-end solutions that address data management, regulatory compliance and market intelligence, for integration with HMS's Prescriber Eligibility® (PE) solution. The enhanced solution will provide the industry with near real-time validation of prescriptive authority for scheduled drugs at the US state and territory level to reduce the risk of regulatory fines and improve third party reimbursement rates, including Medicaid.
Medi-Span is a provider of comprehensive drug information and drug interaction database solutions for more than 35 years. The Controlled Substances File can be implemented to assist pharmacists in dispensing settings to meet mandatory compliance with US regulations of controlled substances by providing regulation schedules, Prescription Drug Monitoring Program (PDMP), and Automation of Reports and Consolidated Orders System (ARCOS) in one data resource.
Health Market Science's PE solution ensures real-time, point-of-service compliance checks against all submitted pharmacy claims before they are transmitted to payers. PE leverages data from the HMS Provider MasterFile, a database of 8 million healthcare practitioners, nearly half a million healthcare organisations, as well as the affiliations between them.
